20.69
-0.27(-1.29%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
1068
First IPO Date
August 24, 2020
| Name | Title | Pay | Year Born |
| Mr. Kaijie Yang | Deputy GM & Chief Financial Officer | 0 | 1970 |
| Mr. Qingfeng Wang | Board Secretary | 0 | 1989 |
| Ms. Jian Zhou | Chairman of the Supervisory Board & Assistant to the GM | 0 | 1974 |
| Mr. Wenge Ding | Product & Technical Service Director and Supervisor | 0 | 1969 |
| Ms. Hongxia Li | Director of Warehousing & Logistics Data and Supervisor | 0 | 1976 |
| Mr. Jie Han | Deputy General Manager | 0 | 1985 |
| Mr. Zexiang Liu | Director & Assistant to the GM | 0 | 1976 |
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. is based in Wuhan, China.